Non classé

Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer

On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin...

Read

Nutrition Position Paper

Nutritional intervention is essential to cancer treatments. It can reduce hospitalisation length and treatment-related toxicity while improving nut...

Read

CRC Patients and Caregivers, Join the European Community of COLONTOWN!

Read

National Cancer Center Japan Asks for Your Support on a Project to Impact Patient Engagement

Would you like to know how and where patient engagement is happening in R&D? Would you like to see an objective comparison between Europe and J...

Read

Digestive Health Community Support for the Proposed EU Cancer Screening Recommendations

DiCE and United European Gastroenterology (UEG) issued a letter of support for the European Commission’s proposal.

Read

My Food Podcast

Read

Pancreatic Cancer White Paper

Read

Medical Knowledge at Patient Level

Read

Colonoscopies DO Save Lives!

A study recently published in the New England Journal of Medicine created much buzz in mid-October, questioning the usefulness of colonoscopies as ...

Read

DiCE participated in the successful in-person Patient Engagement Open Forum (#PEOF2022) in Barcelona!

DiCE participated in three exciting days of innovative and inspiring live workshops. The patient & people-centric sessions offered the chance t...

Read